The Role of Leptin in Antipsychotic-Induced Weight Gain: Genetic and Non-Genetic Factors
Schizophrenia is a chronic and disabling mental illness affecting millions of people worldwide. A greater proportion of people with schizophrenia tends to be overweight. Antipsychotic medications have been considered the primary risk factor for obesity in schizophrenia, although the mechanisms by wh...
Saved in:
Main Authors: | Fabio Panariello, Gina Polsinelli, Carol Borlido, Marcellino Monda, Vincenzo De Luca |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Journal of Obesity |
Online Access: | http://dx.doi.org/10.1155/2012/572848 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association of leptin receptor Gln223Arg genetic polymorphism with obesity and non-alcoholic fatty liver disease
by: A. V. Morozova, et al.
Published: (2014-09-01) -
The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review
by: Catthoor Kirsten, et al. -
Hormonal Changes in Menopause and Orexin-A Action
by: Giovanni Messina, et al.
Published: (2013-01-01) -
Clozapine-Induced Phototoxicity: An Unusual Side Effect of Atypical Antipsychotics
by: S. Al-Aojan, et al.
Published: (2018-01-01) -
Appropriate Weight Gain During Pregnancy
by: Stephanie Allen, et al.
Published: (2012-08-01)